Skip to main content
SpringerLink
Log in

Frequency and Significance of Antibodies to Chromatin in Autoimmune Hepatitis

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Our aims were to determine the frequency and prognostic implications of antibodies to chromatin in autoimmune hepatitis. Three hundred seventy-one serum samples from 172 patients were tested by enzyme-linked immunosorbent assay. Sixty-seven patients (39%) had antibodies to chromatin. Percent positivity was greater in men than women (58% vs 34%, P = 0.008), and seropositivity was associated with higher serum levels of γ-globulin and immunoglobulin G. Antibodies to chromatin disappeared in 25 of 60 patients who were tested successively (42%), and they were more common in samples obtained during active than inactive disease (32% vs 19%, P = 0.01). Relapse after drug withdrawal occurred more often in seropositive patients (91% vs 66%, P = 0.002). We conclude that antibodies to chromatin occur commonly in autoimmune hepatitis, and they are associated with disease activity. Percent positivity is greater in men than women, and seropositivity identifies individuals who commonlyrelapse after drug withdrawal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Czaja AJ, Homburger HA: Autoantibodies in liver disease. Gastroenterology 120: 239–249, 2001

    Google Scholar 

  2. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg J-C, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed WD, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929–938, 1999

    Google Scholar 

  3. Czaja AJ, Freese DK: Diagnosis and treatment of autoimmune hepatitis. Hepatology 36: 479–497, 2002

    Google Scholar 

  4. Czaja AJ: Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 30: 394–401, 1999

    Google Scholar 

  5. Targan SR, Landers C, Vidrich A, Czaja AJ: High-titer antineutrophil cytoplasmic antibodies in type 1 autoimmune hepatitis. Gastroenterology 108: 1159–1166, 1995

    Google Scholar 

  6. Zauli D, Ghetti S, Grassi A, Descovich C, Cassani F, Ballardini G, Muratori L, Bianchi FB: Antineutrophil cytoplasmic antibodies in type 1 and type 2 autoimmune hepatitis. Hepatology 25: 1105–1107, 1997

    Google Scholar 

  7. Czaja AJ, Ming C, Shirai M, Nishioka M: Frequency and significance of antibodies to histones in autoimmune hepatitis. J Hepatol 23: 32–38, 1995

    Google Scholar 

  8. Chen M, Shirai M, Czaja AJ, Kurokohchi K, Arichi T, Arima K, Kodama T, Nishioka M: Characterization of antihistone antibodies in patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol 13: 483–489, 1998

    Google Scholar 

  9. Fritzler MJ: Autoantibodies: diagnostic fingerprints and etiologic perplexities. Clin Invest Med 20: 50–66, 1997

    Google Scholar 

  10. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24: 1068–1073, 1996

    Google Scholar 

  11. Czaja AJ, Morshed SA, Parveen S, Nishioka M: Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis. Hepatology 26: 567–572, 1997

    Google Scholar 

  12. McFarlane IG, Hegarty JE, McSorley CG, McFarlane BM, Williams R: Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet 2: 954–956, 1984

    Google Scholar 

  13. Czaja AJ, Pfeifer KD, Decker RH, Vallari AS: Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci 41: 1733–1740, 1996

    Google Scholar 

  14. Czaja AJ, Donaldson PT, Lohse AW: Antibodies to soluble liver antigen/liver pancreas and HLA risk factors in type 1 autoimmune hepatitis. Am J Gastroenterol 97: 413–419, 2002

    Google Scholar 

  15. Baeres M, Herkel J, Czaja AJ, Wies I, Kanzler S, Cancado ELR, Porta G, Nishioka M, Simon T, Daehnrich C, Schlumberger W, Galle PR, Lohse AW: Establishment of standardized SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence and clinical characteristics. Gut 51: 259–264, 2002

    Google Scholar 

  16. Li L, Chen M, Huang DY, Nishioka M: Frequency and significance of antibodies to chromatin in autoimmune hepatitis type 1. J Gastroenterol Hepatol 15: 1176–1782, 2000

    Google Scholar 

  17. Doenecke D, Albig W, Bode C, Drabent B, Franke K, Gavenis K, Witt O: Histones: genetic diversity and tissue-specific gene expression. Histochem Cell Biol 107: 1–10, 1997

    Google Scholar 

  18. Rubin RL: Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs. Clin Biochem 25: 223–234, 1992

    Google Scholar 

  19. Mohan CH, Adams S, Stanik V, Datta SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177: 1367–1381, 1993

    Google Scholar 

  20. Amoura Z, Koutouzov S, Piette J-C: The role of nucleosomes in lupus. Curr Opin Rheumatol 12: 369–373, 2000

    Google Scholar 

  21. Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach JF, Jacob L: Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antiihistone antibodies in serum of MRL-Mp lpr/lpr and C / C mice and are present in kidney eluates. Arthritis Rheum 37: 1684–1688, 1994

    Google Scholar 

  22. Burlingame RW, Boey ML, Starkebaum G, Rubin RL: The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 94: 184–192, 1994

    Google Scholar 

  23. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johson PJ, Williams R: Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13: 701–706, 1991

    Google Scholar 

  24. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105: 1502–1507, 1993

    Google Scholar 

  25. Czaja AJ, Nishioka M, Morshed SA, Hachiya T: Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 107: 200–207, 1994

    Google Scholar 

  26. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci 42: 1688–1696, 1997

    Google Scholar 

  27. Homburger HA, Cahen YD, Griffiths J, Jacob GL: Detection of antinuclear antibodies. Comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Med 122: 993–999, 1998

    Google Scholar 

  28. Czaja AJ, Manns MP, Homburger HA: Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103: 1290–1295, 1992

    Google Scholar 

  29. Czaja AJ: Drug therapy in the management of type 1 autoimmune hepatitis. Drugs 57: 49–68, 1999

    Google Scholar 

  30. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH: Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 16: 876–883, 1975

    Google Scholar 

  31. Czaja AJ, Wolf AM, Baggenstoss AH: Laboratory assessment of severe chronic active liver disease (CALD): correlation of serum transaminase and gamma globulin levels with histologic features. Gastroenterology 80: 687–692, 1981

    Google Scholar 

  32. Czaja AJ, Menon KVN, Carpenter HA: Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology 35: 890–897, 2002

    Google Scholar 

  33. Tan EM: Autoantibodies to nuclear antigens: their immunology and meaning. Adv Immunol 33: 167–240, 1982

    Google Scholar 

  34. Strettell MDJ, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, Williams R: Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 112: 2028–2035, 1997

    Google Scholar 

  35. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R: Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 25: 317–323, 1997

    Google Scholar 

  36. Czaja AJ, Santrach PJ, Moore SB: Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci 46: 140–147, 2001

    Google Scholar 

  37. Hall S, Czaja AJ, Kaufman DK, Markowitz H, Ginsburg WW: How lupoid is lupoid hepatitis? J Rheumatol 13: 95–98, 1986

    Google Scholar 

  38. Wood JR, Czaja AJ, Beaver SJ, Hall S, Ginsburg WW, Kaufman DK, Markowitz H: Frequency and significance of antibody to double-stranded DNA in chronic active hepatitis. Hepatology 6: 976–980, 1986

    Google Scholar 

  39. Czaja AJ: Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol 96: 1224–1231, 2001

    Google Scholar 

  40. Parveen S, Morshed SA, Arima K, Nishioka M, Czaja AJ, Chow C, Ng H-S: Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia. Dig Dis Sci 43: 1322–1331, 1998

    Google Scholar 

  41. Walport MJ: Lupus, DNase and defective disposal of cellular debris. Nature Genet 25: 135–136, 2000

    Google Scholar 

  42. Doherty DG, Penzotti JE, Koelle DM, Kwok WW, Lybrand TP, Masewicz S, Nepom GT: Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. J Immunol 161: 3527–3535, 1998

    Google Scholar 

  43. Czaja AJ, Doherty DG, Donaldson PT: Genetic bases of autoimmune hepatitis. Dig Dis Sci 47: 2139–2150, 2002

    Google Scholar 

  44. Czaja AJ: Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 30: 394–401, 1999

    Google Scholar 

  45. Czaja AJ, Donaldson PT: Gender effects and synergism with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol 97: 2051–2057, 2002

    Google Scholar 

  46. Whitacre CC, Reingold SC, O'Looney PA: A gender gap in autoimmunity. Science 283: 1277–1278, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota

    Albert J. Czaja

  2. INOVA Diagnostics, San Diego, California, USA

    Zakera Shums, Walter L. Binder, Stephen J. Lewis, Vicki J. Nelson & Gary L. Norman

Authors
  1. Albert J. Czaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zakera Shums
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Walter L. Binder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephen J. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vicki J. Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gary L. Norman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Czaja, A.J., Shums, Z., Binder, W.L. et al. Frequency and Significance of Antibodies to Chromatin in Autoimmune Hepatitis. Dig Dis Sci 48, 1658–1664 (2003). https://doi.org/10.1023/A:1024748714580

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024748714580

Search

Navigation